Halozyme Therapeutics Inc (NASDAQ:HALO)
| 35.70 Delayed Data As of 3:59pm ET |  +1.21 / +3.51%Today’s Change | 32.83 Today|||52-Week Range 59.46 | -37.26% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $4.7B |
Company Description
There is no company description available for Halozyme Therapeutics Inc.
Contact Information
-- -- -- -- -- | P: Investor Relations: -- |
Employees
Shareholders
| Mutual fund holders | 60.01% |
| Other institutional | 36.69% |
| Individual stakeholders | 17.76% |
Top Executives
| There are no executives to display. |
